Five items. Three Australian health and biotech raises are on the public record. No new Australian GP practice deal has reached the ACCC register since Partnered Health's 3 July notification, and that matter is still without a determination.
Radiopharm Theranostics (ASX:RAD) announced the two offers together on 24 July: a US$4.1m registered direct offering of American depositary shares in the United States and an Australian placement and share purchase plan of up to about A$12.7m. Institutions have committed about A$6.7m, and the share purchase plan is open to Australian and New Zealand holders for up to about A$6m. Options attach one for one, exercisable at A$0.018 and expiring on 31 July 2029.
Shareholders vote on 11 September and the new securities list on 17 September. Proceeds fund the planned Phase 3 registrational study for RAD101.
Vitrafy Life Sciences (ASX:VFY) raised A$30m in a placement priced at $2.60 a share. Bell Potter lifted its price target after the placement, reading the raise as growth funding. The Motley Fool Australia reported the upgrade on 24 June.
Everlab, a Melbourne preventive healthcare company, raised A$65m in a Series A led by Airtree, with proceeds funding a global rollout. Pulse+IT reported the round on 17 June.
No new Australian GP practice acquisition has reached the ACCC acquisitions register since Partnered Health's Ryan Plaza notification on 3 July. That matter, MN-15027, a bid for the 11-GP Medicine on Second clinic at Maroochydore, is still at Phase 1 with no determination published, and the statutory determination period runs to 14 August.
The Bupa-Partnered Health parent transaction has not appeared as a separate notification, and the Foreign Investment Review Board approval that deal needs is outstanding. In New Zealand, Green Cross Health's NZD 270m sale of The Doctors to Tend Health is due to complete on 31 July. Shareholders approved it on 14 July, in a poll result filed with the NZX as announcement 476097, and no completion notice has been posted.
Medius first observed each of the four listings on 27 July 2026. Town, state, GP count and source as the broker publishes them; anonymous listings are not named.
Own a practice and thinking about your exit, this year or in three? Write to kate.marie@mediusglobal.com.au, in confidence.
Buying, lending or researching? The full operator dataset behind the Zoo is licensed: get the full data.